Eribulin Does Not Prevent Epithelial-to-Mesenchymal Transition in HT-29 Intestinal Epithelial Cells

BACKGROUND: Fistula formation affects up to 50$ of Crohn's disease (CD) patients and causes considerable morbidity. Current pharmacological management mainly includes antibiotics, immunosuppressives, and anti-TNF antibodies. CD fistulas develop from intestinal epithelial cells undergoing epithe...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Inflamm Intest Dis
Glavni autori: Leutenegger, Martin, Bruckner, Ramona, Spalinger, Marianne R., Lang, Silvia, Rogler, Gerhard, Scharl, Michael
Format: Artigo
Jezik:Inglês
Izdano: S. Karger AG 2018
Teme:
Original Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6135225/
https://ncbi.nlm.nih.gov/pubmed/30221148
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000490052
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items